![Adrian Howd](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Adrian Howd
Director of Finance/CFO at
BIVICTRIX THERAPEUTICS PLC
Profile
Adrian G.
Howd is currently the Director at Viamet Pharmaceuticals, Inc., Independent Director at Viamet Pharmaceuticals Corp., Director & Principal at Brandon Point Industries Ltd., Director at Blueberry Therapeutics Ltd., and will be the Chief Financial & Business Officer at BiVictriX Therapeutics Plc starting in 2023.
Previously, he was the Chief Executive Officer at Malin Corp.
Plc from 2015 to 2018.
He also served as a Non-Executive Director at Kymab Ltd., Director at Poseida Therapeutics, Inc., Director at Wavebreak Therapeutics Ltd. from 2016 to 2018, Non-Executive Director at Immunocore Holdings Plc, and Executive Vice President at Evotec SE.
Dr. Howd started his career as a Research Analyst at ABN AMRO Bank NV (London Branch) in 2008 and later worked as a Research Analyst at Joh.
Berenberg, Gossler & Co. KG (United Kingdom) from 2009 to 2013.
He holds a doctorate degree from the University of London.
Adrian Howd active positions
| Companies | Position | Start |
|---|---|---|
| BIVICTRIX THERAPEUTICS PLC | Director of Finance/CFO | 2023-10-02 |
Brandon Point Industries Ltd.
 Brandon Point Industries Ltd. Medical/Nursing ServicesHealth Services Operates as a life sciences company | Director/Board Member | - |
Viamet Pharmaceuticals Corp.
 Viamet Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Develops therapeutic drugs using proprietary metalloenzyme medicinal chemistry | Director/Board Member | - |
Viamet Pharmaceuticals, Inc.
 Viamet Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops inhibitors of validated metalloenzymes | Director/Board Member | - |
Blueberry Therapeutics Ltd.
 Blueberry Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Engages in drug research and development | Director/Board Member | - |
Former positions of Adrian Howd
| Companies | Position | End |
|---|---|---|
Wavebreak Therapeutics Ltd.
 Wavebreak Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Develops small molecule therapeutics for multiple protein misfolding diseases | Director/Board Member | 2018-10-27 |
| MALIN CORPORATION PLC | Chief Executive Officer | 2015-08-23 |
Joh. Berenberg, Gossler & Co. KG (United Kingdom)
 Joh. Berenberg, Gossler & Co. KG (United Kingdom) Investment Banks/BrokersFinance Provides brokerage services | Analyst-Equity | 2013-05-31 |
ABN AMRO Bank NV (London Branch) (Broker) (Old)
 ABN AMRO Bank NV (London Branch) (Broker) (Old) Regional BanksFinance Commercial foreign bank. | Analyst-Equity | 2008-04-15 |
| ░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - |
Training of Adrian Howd
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
72
1st degree connections
14
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 14 |
|---|---|
Viamet Pharmaceuticals, Inc.
Viamet Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops inhibitors of validated metalloenzymes | Health Technology |
Viamet Pharmaceuticals Corp.
Viamet Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Develops therapeutic drugs using proprietary metalloenzyme medicinal chemistry | Health Technology |
Malin Corp. Plc
 Malin Corp. Plc BiotechnologyHealth Technology Provides life science services | Health Technology |
Evotec SE
 Evotec SE Miscellaneous Commercial ServicesCommercial Services Provides drug discovery and development services | Commercial Services |
ABN AMRO Bank NV (London Branch) (Broker) (Old)
ABN AMRO Bank NV (London Branch) (Broker) (Old) Regional BanksFinance Commercial foreign bank. | Finance |
University of London
 University of London Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Joh. Berenberg, Gossler & Co. KG (United Kingdom)
Joh. Berenberg, Gossler & Co. KG (United Kingdom) Investment Banks/BrokersFinance Provides brokerage services | Finance |
Kymab Ltd.
 Kymab Ltd. Pharmaceuticals: MajorHealth Technology Discovers and develops human monoclonal antibody drugs | Health Technology |
Brandon Point Industries Ltd.
Brandon Point Industries Ltd. Medical/Nursing ServicesHealth Services Operates as a life sciences company | Health Services |
Blueberry Therapeutics Ltd.
Blueberry Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Engages in drug research and development | Health Technology |
Poseida Therapeutics, Inc.
 Poseida Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company which develops next generation cell and gene therapeutics | Health Technology |
Wavebreak Therapeutics Ltd.
Wavebreak Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Develops small molecule therapeutics for multiple protein misfolding diseases | Health Technology |
BiVictriX Therapeutics Plc
 BiVictriX Therapeutics Plc Pharmaceuticals: MajorHealth Technology Develops and distributes cancer therapeutics | Health Technology |
Immunocore Holdings Plc
 Immunocore Holdings Plc BiotechnologyHealth Technology Operates as a biotechnology company which develops immunotherapies | Health Technology |
- Stock Market
- Insiders
- Adrian Howd
